Literature DB >> 20408548

Structural evidence that human acetylcholinesterase inhibited by tabun ages through O-dealkylation.

Eugénie Carletti1, Jacques-Philippe Colletier, Florine Dupeux, Marie Trovaslet, Patrick Masson, Florian Nachon.   

Abstract

Tabun is a warfare agent that inhibits human acetylcholinesterase (hAChE) by rapid phosphylation of the catalytic serine. A time-dependent reaction occurs on the tabun adduct, leading to an "aged" enzyme, resistant to oxime reactivators. The aging reaction may proceed via either dealkylation or deamidation, depending on the stereochemistry of the phosphoramidyl adduct. We solved the X-ray structure of aged tabun-hAChE complexed with fasciculin II, and we show that aging proceeds through O-dealkylation, in agreement with the aging mechanism that we determined for tabun-inhibited human butyrylcholinesterase and mouse acetylcholinesterase. Noteworthy, aging and binding of fasciculin II lead to an improved thermostability, resulting from additional stabilizing interactions between the two subdomains that face each other across the active site gorge. This first structure of hAChE inhibited by a nerve agent provides structural insight into the inhibition and aging mechanisms and a structural template for the design of molecules capable of reactivating aged hAChE.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20408548     DOI: 10.1021/jm901853b

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  15 in total

1.  Productive reorientation of a bound oxime reactivator revealed in room temperature X-ray structures of native and VX-inhibited human acetylcholinesterase.

Authors:  Oksana Gerlits; Xiaotian Kong; Xiaolin Cheng; Troy Wymore; Donald K Blumenthal; Palmer Taylor; Zoran Radić; Andrey Kovalevsky
Journal:  J Biol Chem       Date:  2019-05-28       Impact factor: 5.157

2.  Influence of gauche effect on uncharged oxime reactivators for the reactivation of tabun-inhibited AChE: quantum chemical and steered molecular dynamics studies.

Authors:  Shibaji Ghosh; Kalyanashis Jana; Bishwajit Ganguly
Journal:  J Comput Aided Mol Des       Date:  2018-07-06       Impact factor: 3.686

3.  Molecular docking and receptor-specific 3D-QSAR studies of acetylcholinesterase inhibitors.

Authors:  Pran Kishore Deb; Anuradha Sharma; Poonam Piplani; Raghuram Rao Akkinepally
Journal:  Mol Divers       Date:  2012-09-21       Impact factor: 2.943

Review 4.  Efforts toward treatments against aging of organophosphorus-inhibited acetylcholinesterase.

Authors:  Qinggeng Zhuang; Amneh Young; Christopher S Callam; Craig A McElroy; Özlem Dogan Ekici; Ryan J Yoder; Christopher M Hadad
Journal:  Ann N Y Acad Sci       Date:  2016-06-21       Impact factor: 5.691

5.  Resolving pathways of interaction of mipafox and a sarin analog with human acetylcholinesterase by kinetics, mass spectrometry and molecular modeling approaches.

Authors:  I Mangas; P Taylor; E Vilanova; J Estévez; T C C França; E Komives; Z Radić
Journal:  Arch Toxicol       Date:  2015-03-06       Impact factor: 5.153

6.  Kinetic assessment of N-methyl-2-methoxypyridinium species as phosphonate anion methylating agents.

Authors:  Joseph J Topczewski; Daniel M Quinn
Journal:  Org Lett       Date:  2013-02-14       Impact factor: 6.005

7.  Structural study of the complex stereoselectivity of human butyrylcholinesterase for the neurotoxic V-agents.

Authors:  Marielle Wandhammer; Eugénie Carletti; Marcel Van der Schans; Emilie Gillon; Yvain Nicolet; Patrick Masson; Maurice Goeldner; Daan Noort; Florian Nachon
Journal:  J Biol Chem       Date:  2011-03-23       Impact factor: 5.157

8.  Crystal structure of snake venom acetylcholinesterase in complex with inhibitory antibody fragment Fab410 bound at the peripheral site: evidence for open and closed states of a back door channel.

Authors:  Yves Bourne; Ludovic Renault; Pascale Marchot
Journal:  J Biol Chem       Date:  2014-11-19       Impact factor: 5.157

9.  Mass spectrometry method to identify aging pathways of Sp- and Rp-tabun adducts on human butyrylcholinesterase based on the acid labile P-N bond.

Authors:  Wei Jiang; John R Cashman; Florian Nachon; Patrick Masson; Lawrence M Schopfer; Oksana Lockridge
Journal:  Toxicol Sci       Date:  2013-01-23       Impact factor: 4.849

10.  New therapeutic approaches and novel alternatives for organophosphate toxicity.

Authors:  Francine S Katz; Stevan Pecic; Laura Schneider; Zhengxiang Zhu; Ashley Hastings; Michal Luzac; Joanne Macdonald; Donald W Landry; Milan N Stojanovic
Journal:  Toxicol Lett       Date:  2018-03-31       Impact factor: 4.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.